Player FM - Internet Radio Done Right
40 subscribers
Checked 4M ago
Tilføjet eight år siden
Indhold leveret af MediCom Oncology. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af MediCom Oncology eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Player FM - Podcast-app
Gå offline med appen Player FM !
Gå offline med appen Player FM !
Podcasts der er værd at lytte til
SPONSORERET
T
The Agile Brand with Greg Kihlström®
1 #625: Creating an agile brand with composable approaches, featuring Chris Bach 47:35
47:35
Afspil senere
Afspil senere
Lister
Like
Liked
47:35“Software is eating the world.” That was written over 14 years ago, back in 2011 by Marc Andreesen, and it seems like that is growing more true every day. Today we’re going to talk about the increasingly digital nature of businesses - all businesses - as well as how the concept of composability, which has been applied effectively in the world of software, might just have applications well beyond technology infrastructure. To help me discuss this topic, I’d like to welcome Chris Bach, Co-Founder of Netlify. RESOURCES Wix Studio is the ultimate web platform for creative, fast-paced teams at agencies and enterprises—with smart design tools, flexible dev capabilities, full-stack business solutions, multi-site management, advanced AI and fully managed infrastructure. https://www.wix.com/studio Don't miss Medallia Experience 2025, March 24-26 in Las Vegas: Registration is now available: https://cvent.me/AmO1k0 Use code MEDEXP25 for $200 off registration Register now for HumanX 2025. This AI-focused event which brings some of the most forward-thinking minds in technology together. Register now with the code "HX25p_tab" for $250 off the regular price. Connect with Greg on LinkedIn: https://www.linkedin.com/in/gregkihlstrom Don't miss a thing: get the latest episodes, sign up for our newsletter and more: https://www.theagilebrand.show Check out The Agile Brand Guide website with articles, insights, and Martechipedia, the wiki for marketing technology: https://www.agilebrandguide.com The Agile Brand podcast is brought to you by TEKsystems. Learn more here: https://www.teksystems.com/versionnextnow The Agile Brand is produced by Missing Link—a Latina-owned strategy-driven, creatively fueled production co-op. From ideation to creation, they craft human connections through intelligent, engaging and informative content. https://www.missinglink.company…
Standard dosing and delivery of FOLFIRINOX
Manage episode 178003681 series 1375096
Indhold leveret af MediCom Oncology. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af MediCom Oncology eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Listen as Dr. Andrea Wang-Gillam explains standard dosing and delivery of FOLFIRNOX in patients with pancreatic cancer.
…
continue reading
53 episoder
Manage episode 178003681 series 1375096
Indhold leveret af MediCom Oncology. Alt podcastindhold inklusive episoder, grafik og podcastbeskrivelser uploades og leveres direkte af MediCom Oncology eller deres podcastplatformspartner. Hvis du mener, at nogen bruger dit ophavsretligt beskyttede værk uden din tilladelse, kan du følge processen beskrevet her https://da.player.fm/legal.
Listen as Dr. Andrea Wang-Gillam explains standard dosing and delivery of FOLFIRNOX in patients with pancreatic cancer.
…
continue reading
53 episoder
Alle episoder
×M
MediCom Oncology Clinical Pearls Podcasts
1 Third-generation FLT3 inhibitors in clinical development 2:42
2:42
Afspil senere
Afspil senere
Lister
Like
Liked
2:42Dr. Perl provides a brief summary of what is on the horizon for FLT3 inhibitors in AML.
M
MediCom Oncology Clinical Pearls Podcasts
1 CAR T case study in acute myeloid leukemia 5:49
5:49
Afspil senere
Afspil senere
Lister
Like
Liked
5:49Dr. Sallman describes a patient case demonstrating promise in the further study and potential use of CAR T-cell therapy for patients with AML.
M
MediCom Oncology Clinical Pearls Podcasts
1 Key considerations when prescribing midostaurin with a strong CYP3A4 inhibi 2:23
2:23
Afspil senere
Afspil senere
Lister
Like
Liked
2:23Dr. Perl gives guidance on providing optimal patient therapy when prescribing midostaurin with a strong CYP3A4 inhibitor.
M
MediCom Oncology Clinical Pearls Podcasts
1 How to proceed with a patient who presents with idiopathic cytopenia of undetermined significance 3:58
3:58
Afspil senere
Afspil senere
Lister
Like
Liked
3:58In this audio activity, Dr. Goldberg describes his approach to patients with idiopathic or clonal cytopenias of undetermined significance (ICUS and CCUS).
M
MediCom Oncology Clinical Pearls Podcasts
1 When to consider iron chelation therapy for a transplant-eligible patient 3:56
3:56
Afspil senere
Afspil senere
Lister
Like
Liked
3:56Listen as Dr. Goldberg explains his approach to iron chelation therapy in patients who are, or may be within the next 5-10 years, eligible for transplant.
M
MediCom Oncology Clinical Pearls Podcasts
1 53-year-old woman presenting with severe fatigue and bruising 3:58
3:58
Afspil senere
Afspil senere
Lister
Like
Liked
3:58Hematopathologist Dr. Khoury presents a case snapshot showing the complexities of diagnosing AML, describing the importance of morphology, flow cytometry, cytogenetics, and molecular diagnostics.
M
MediCom Oncology Clinical Pearls Podcasts
1 New subcategories of pancreatic cancer allow for a biomarker-driven approach to therapy 4:00
4:00
Afspil senere
Afspil senere
Lister
Like
Liked
4:00Dr. O'Reilly discusses the new subcategories of pancreatic cancer that have emerged, and which are laying the groundwork for a biomarker-driven approach to therapy.
M
MediCom Oncology Clinical Pearls Podcasts
1 What are the unique aspects of pancreas cancer that lead to the development of novel therapeutics? 2:40
2:40
Afspil senere
Afspil senere
Lister
Like
Liked
2:40Dr. O'Reilly discusses the unique pathophysiology of pancreas cancer that must be considered in the development of novel therapeutics.
M
MediCom Oncology Clinical Pearls Podcasts
1 Predictors of response to lenalidomide in a non-del(5q) MDS patient 3:03
3:03
Afspil senere
Afspil senere
Lister
Like
Liked
3:03Listen as Dr. Goldberg discusses, in just under two minutes, the predictors of response to lenalidomide in a non-del(5q) MDS patient.
M
MediCom Oncology Clinical Pearls Podcasts
1 What are the pros and cons of radiation therapy? 2:29
2:29
Afspil senere
Afspil senere
Lister
Like
Liked
2:29Listen as Dr. Matasar discusses the pros and cons of radiation therapy, and who should be offered this therapy.
M
MediCom Oncology Clinical Pearls Podcasts
1 What defines high-quality survivorship care for patients treated for classical Hodgkin lymphoma? 3:01
3:01
Afspil senere
Afspil senere
Lister
Like
Liked
3:01Listen as Dr. Matasar discusses survivorship care for patients who have been treated for classical Hodgkin lymphoma, including late effects of treatment.
M
MediCom Oncology Clinical Pearls Podcasts
1 Second primary malignancies associated with lenalidomide maintenance 2:53
2:53
Afspil senere
Afspil senere
Lister
Like
Liked
2:53Dr. Jacob Laubach discusses second primary malignancies associated with lenalidomide maintenance in the transplant and post-transplant setting.
M
MediCom Oncology Clinical Pearls Podcasts
1 Impact of consolidation therapy in patients post-transplant 3:09
3:09
Afspil senere
Afspil senere
Lister
Like
Liked
3:09Dr. Laubach discusses the impact of consolidation therapy in patients post-transplant, referencing results of the CTN StaMINA trial.
M
MediCom Oncology Clinical Pearls Podcasts
1 Bortezomib as an alternate strategy for maintenance therapy. 2:32
2:32
Afspil senere
Afspil senere
Lister
Like
Liked
2:32Dr. Jacob Laubach discusses bortezomib as an alternate strategy to lenalidomide for maintenance therapy in patients with multiple myeloma.
M
MediCom Oncology Clinical Pearls Podcasts
1 What may be the future role for brentuximab vedotin in newly diagnosed Hodgkin lymphoma? 2:35
2:35
Afspil senere
Afspil senere
Lister
Like
Liked
2:35Listen as Dr. Matasar discusses the future role of brentuximab vedotin in patients with newly diagnosed classical Hodgkin lymphoma.
Velkommen til Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.